To Relieve Pain in Vataja Gridhrisi (Sciatica) with Nirgundi Taila Matra Vasti And Investigating Its Bioavailability

Effectiveness of Nirgundi Taila Matra Vasti in Alleviating Pain Associated With Vataja Gridhrisi (Sciatica) And Investigating Its Bioavailability: An Open-Labelled, Single Arm, Exploratory Clinical Trial. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/088716

Enrollment

Registered

2025-06-12

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G55- Nerve root and plexus compressionsin diseases classified elsewhere

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients presenting with clinical features of Gridhrasi (sciatica). 2 Gridhrasi (sciatica) patients with type 2 diabetes mellitus and hypercholestremia will be evaluated separately to see whether these diseases affect the efficacy and bio-availability of Nirgundi Taila Matra Vasti. 3 SLR test ranging between 310-700. 4 Patients willing to sign the consent form.

Exclusion criteria

Exclusion criteria: 1 Subjects of either sex having age below 18 years and above 60 years. 2 Patients having cardiac diseases, renal diseases, endocrine disorders and other systemic disorders. 3 Diagnosed cases of tuberculosis of spine, spinal tumors, vertebral fractures, surgical conditions, hyperuricaemia and autoimmune diseases like RA, ankylosing spondylitis. 4 Pregnant and lactating women. 5 Patient who had taken the Nirgundi in any form before starting the trial

Design outcomes

Primary

Measure	Time frame
1.To evaluate the efficacy of Nirgundi Taila Matra Vasti in alleviating pain associated with Vataja Gridhrasi (sciatica). 2.To assess the improvement in signs and symptoms of Vataja Gridhrasi (sciatica). Timepoint: 0 DAY, 7 DAY, 14 DAY	—

Secondary

Measure	Time frame
1. To assess the bio-availability of Nirgundi Taila when administered through rectal routeTimepoint: 0 DAY, 7 DAY, 14 DAY	—

Countries

India

Contacts

Public ContactDr Preetpal Singh

Glocal University

singhpreet523@gmail.com7015367776

Outcome results